Insilico Medicine Announce US$888 Million Multi-Year Collaboration with Servier for Drug Discovery and Development in Oncology
This item is under embargo and is only visible to journalists
Please login here
Regions: Asia, Hong Kong
Keywords: Business, Medical & pharmaceutical
Disclaimer: AlphaGalileo is not responsible for the accuracy of content posted to AlphaGalileo by contributing institutions or for the use of any information through the AlphaGalileo system.
The item has been withdrawn. If you are a journalists please contact the person that posted the item with any questions.